Supernus acquires epilepsy start-up Biscayne Neurotherapeutics for up to $183mm
Drug Discovery Tools
- Natural Products
- Molecular Diversity
- Drug Discovery Tools
- Full Acquisition
- Payment Includes Cash
- Includes Earnout
- Intra-Biotech Deal
- Acquisition of Private Biotech
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.